The effectiveness and cost effectiveness of dark chocolate consumption as prevention therapy in people at high risk of cardiovascular disease: best case scenario analysis using a Markov model
- PMID: 22653982
- PMCID: PMC3365141
- DOI: 10.1136/bmj.e3657
The effectiveness and cost effectiveness of dark chocolate consumption as prevention therapy in people at high risk of cardiovascular disease: best case scenario analysis using a Markov model
Abstract
Objective: To model the long term effectiveness and cost effectiveness of daily dark chocolate consumption in a population with metabolic syndrome at high risk of cardiovascular disease.
Design: Best case scenario analysis using a Markov model.
Setting: Australian Diabetes, Obesity and Lifestyle study.
Participants: 2013 people with hypertension who met the criteria for metabolic syndrome, with no history of cardiovascular disease and not receiving antihypertensive therapy.
Main outcome measures: Treatment effects associated with dark chocolate consumption derived from published meta-analyses were used to determine the absolute number of cardiovascular events with and without treatment. Costs associated with cardiovascular events and treatments were applied to determine the potential amount of funding required for dark chocolate therapy to be considered cost effective.
Results: Daily consumption of dark chocolate (polyphenol content equivalent to 100 g of dark chocolate) can reduce cardiovascular events by 85 (95% confidence interval 60 to 105) per 10,000 population treated over 10 years. $A40 (£25; €31; $42) could be cost effectively spent per person per year on prevention strategies using dark chocolate. These results assume 100% compliance and represent a best case scenario.
Conclusions: The blood pressure and cholesterol lowering effects of dark chocolate consumption are beneficial in the prevention of cardiovascular events in a population with metabolic syndrome. Daily dark chocolate consumption could be an effective cardiovascular preventive strategy in this population.
Conflict of interest statement
Competing interests: All authors have completed the ICMJE uniform disclosure form at
Figures
Similar articles
-
Cost-effectiveness of milk powder fortified with potassium to decrease blood pressure and prevent cardiovascular events among the adult population in China: a Markov model.BMJ Open. 2017 Sep 25;7(9):e017136. doi: 10.1136/bmjopen-2017-017136. BMJ Open. 2017. PMID: 28951410 Free PMC article.
-
Does dark chocolate have a role in the prevention and management of hypertension?: commentary on the evidence.Hypertension. 2010 Jun;55(6):1289-95. doi: 10.1161/HYPERTENSIONAHA.110.151522. Epub 2010 Apr 19. Hypertension. 2010. PMID: 20404213 Review.
-
Results of a Markov model analysis to assess the cost-effectiveness of statin therapy for the primary prevention of cardiovascular disease in Korea: the Korean Individual-Microsimulation Model for Cardiovascular Health Interventions.Clin Ther. 2009 Dec;31(12):2919-30; discussion 2916-8. doi: 10.1016/j.clinthera.2009.12.013. Clin Ther. 2009. PMID: 20110032
-
Effectiveness and cost effectiveness of cardiovascular disease prevention in whole populations: modelling study.BMJ. 2011 Jul 28;343:d4044. doi: 10.1136/bmj.d4044. BMJ. 2011. PMID: 21798967 Free PMC article.
-
Chocolate consumption and cardiometabolic disorders: systematic review and meta-analysis.BMJ. 2011 Aug 26;343:d4488. doi: 10.1136/bmj.d4488. BMJ. 2011. PMID: 21875885 Free PMC article. Review.
Cited by
-
Using digital health technology to evaluate the impact of chocolate on blood pressure: Results from the COCOA-BP study.Cardiovasc Digit Health J. 2020 Oct 22;1(2):89-96. doi: 10.1016/j.cvdhj.2020.08.002. eCollection 2020 Sep-Oct. Cardiovasc Digit Health J. 2020. PMID: 35265879 Free PMC article.
-
A Novel Promising Frontier for Human Health: The Beneficial Effects of Nutraceuticals in Cardiovascular Diseases.Int J Mol Sci. 2020 Nov 18;21(22):8706. doi: 10.3390/ijms21228706. Int J Mol Sci. 2020. PMID: 33218062 Free PMC article. Review.
-
Natural cocoa ingestion reduced liver damage in mice infected with Plasmodium berghei (NK65).Res Rep Trop Med. 2012 Sep 4;3:107-116. doi: 10.2147/RRTM.S33149. eCollection 2012. Res Rep Trop Med. 2012. PMID: 30890870 Free PMC article.
-
Dark Chocolate: Opportunity for an Alliance between Medical Science and the Food Industry?Front Nutr. 2017 Sep 26;4:43. doi: 10.3389/fnut.2017.00043. eCollection 2017. Front Nutr. 2017. PMID: 29034240 Free PMC article.
-
Habitual cocoa intake reduces arterial stiffness in postmenopausal women regardless of intake frequency: a randomized parallel-group study.Clin Interv Aging. 2016 Nov 14;11:1645-1652. doi: 10.2147/CIA.S118152. eCollection 2016. Clin Interv Aging. 2016. PMID: 27881914 Free PMC article. Clinical Trial.
References
-
- World Health Organization. Cardiovascular diseases: fact sheet No 317. WHO, 2007.
-
- Wilson PW, D’Agostino RB, Parise H, Sullivan L, Meigs JB. Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus. Circulation 2005;112:3066-72. - PubMed
-
- Lippi G, Franchini M, Montagnana M, Favaloro EJ, Guidi GC, Targher G. Dark chocolate: consumption for pleasure or therapy? J Throm Thrombolysis 2009;28:482-8. - PubMed
-
- Egan BM, Laken MA, Donovan JL, Woolson RF. Does dark chocolate have a role in the prevention and management of hypertension? Commentary on the evidence. Hypertension 2010;55:1289-95. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous